Reviews Lovenox


No reviews yet.

Lovenox Drug Description
Lovenox
(enoxaparin sodium) Injection for Subcutaneous and Intravenous use


WARNING: SPINAL/EPIDURAL HEMATOMAS
Epidural or spinal hematomas may occur in patients who are anticoagulated
with low molecular weight heparins (LMWH) or heparinoids and are receiving
neuraxial anesthesia or undergoing spinal puncture. These hematomas may result
in long-term or permanent paralysis. Consider these risks when scheduling
patients for spinal procedures. Factors that can increase the risk of developing
epidural or spinal hematomas in these patients include:

Use of indwelling epidural catheters
Concomitant use of other drugs that affect hemostasis, such as non-steroidal
anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants.
A history of traumatic or repeated epidural or spinal punctures
A history of spinal deformity or spinal surgery

Monitor patients frequently for signs and symptoms of neurological impairment.
If neurological compromise is noted, urgent treatment is necessary.
Consider the benefits and risks before neuraxial intervention in patients
anticoagulated or to be anticoagulated for thromboprophylaxis [see WARNINGS
AND PRECAUTIONS and DRUG
INTERACTIONS].

DRUG DESCRIPTION



What are the possible side effects of enoxaparin (Lovenox)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers or call your doctor at once if you have any of these serious side effects:

bleeding that won't stop;
pale skin, easy bruising, unusual weakness;
swelling, bruising, or bleeding where an incision was made during a surgery or other medical procedure;
sudden numbness or weakness,...
Read All Potential Side Effects for Lovenox »




Lovenox is a sterile aqueous solution containing enoxaparin sodium, a low molecular weight heparin. The pH of the injection is 5.5 to 7.5.
Enoxaparin sodium is obtained by alkaline depolymerization of heparin benzyl
ester derived from porcine intestinal mucosa. Its structure is characterized
by a 2-O-sulfo-4-enepyranosuronic acid group at the non-reducing end and a 2-N,6-O-disulfo-D-glucosamine
at the reducing end of the chain. About 20% (ranging between 15% and 25%) of
the enoxaparin structure contains an 1,6 anhydro derivative on the reducing
end of the polysaccharide chain. The drug substance is the sodium salt. The
average molecular weight is about 4500 daltons. The molecular weight distribution
is:
<2000 daltons                ≤20%
2000 to 8000 daltons      ≥68%
>8000 daltons                ≤18%

Structural Formula







*X = Percent of polysaccharide chain containing 1,6 anhydro derivative on the reducing end.
Lovenox 100 mg/mL Concentration contains 10 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1000 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
Lovenox 150 mg/mL Concentration contains 15 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1500 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
The Lovenox prefilled syringes and graduated prefilled syringes are preservative-free
and intended for use only as a single-dose injection. The multiple-dose vial
contains 15 mg benzyl alcohol per 1 mL as a preservative [see DOSAGE
AND ADMINISTRATION and HOW SUPPLIED].
Last reviewed on RxList: 1/8/2010




Lovenox Drug Description
Lovenox
(enoxaparin sodium) Injection for Subcutaneous and Intravenous use


WARNING: SPINAL/EPIDURAL HEMATOMAS
Epidural or spinal hematomas may occur in patients who are anticoagulated
with low molecular weight heparins (LMWH) or heparinoids and are receiving
neuraxial anesthesia or undergoing spinal puncture. These hematomas may result
in long-term or permanent paralysis. Consider these risks when scheduling
patients for spinal procedures. Factors that can increase the risk of developing
epidural or spinal hematomas in these patients include:

Use of indwelling epidural catheters
Concomitant use of other drugs that affect hemostasis, such as non-steroidal
anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants.
A history of traumatic or repeated epidural or spinal punctures
A history of spinal deformity or spinal surgery

Monitor patients frequently for signs and symptoms of neurological impairment.
If neurological compromise is noted, urgent treatment is necessary.
Consider the benefits and risks before neuraxial intervention in patients
anticoagulated or to be anticoagulated for thromboprophylaxis [see WARNINGS
AND PRECAUTIONS and DRUG
INTERACTIONS].

DRUG DESCRIPTION



What are the possible side effects of enoxaparin (Lovenox)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers or call your doctor at once if you have any of these serious side effects:

bleeding that won't stop;
pale skin, easy bruising, unusual weakness;
swelling, bruising, or bleeding where an incision was made during a surgery or other medical procedure;
sudden numbness or weakness,...
Read All Potential Side Effects for Lovenox »




Lovenox is a sterile aqueous solution containing enoxaparin sodium, a low molecular weight heparin. The pH of the injection is 5.5 to 7.5.
Enoxaparin sodium is obtained by alkaline depolymerization of heparin benzyl
ester derived from porcine intestinal mucosa. Its structure is characterized
by a 2-O-sulfo-4-enepyranosuronic acid group at the non-reducing end and a 2-N,6-O-disulfo-D-glucosamine
at the reducing end of the chain. About 20% (ranging between 15% and 25%) of
the enoxaparin structure contains an 1,6 anhydro derivative on the reducing
end of the polysaccharide chain. The drug substance is the sodium salt. The
average molecular weight is about 4500 daltons. The molecular weight distribution
is:
<2000 daltons                ≤20%
2000 to 8000 daltons      ≥68%
>8000 daltons                ≤18%

Structural Formula







*X = Percent of polysaccharide chain containing 1,6 anhydro derivative on the reducing end.
Lovenox 100 mg/mL Concentration contains 10 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1000 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
Lovenox 150 mg/mL Concentration contains 15 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1500 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
The Lovenox prefilled syringes and graduated prefilled syringes are preservative-free
and intended for use only as a single-dose injection. The multiple-dose vial
contains 15 mg benzyl alcohol per 1 mL as a preservative [see DOSAGE
AND ADMINISTRATION and HOW SUPPLIED].
Last reviewed on RxList: 1/8/2010




Lovenox Drug Description
Lovenox
(enoxaparin sodium) Injection for Subcutaneous and Intravenous use


WARNING: SPINAL/EPIDURAL HEMATOMAS
Epidural or spinal hematomas may occur in patients who are anticoagulated
with low molecular weight heparins (LMWH) or heparinoids and are receiving
neuraxial anesthesia or undergoing spinal puncture. These hematomas may result
in long-term or permanent paralysis. Consider these risks when scheduling
patients for spinal procedures. Factors that can increase the risk of developing
epidural or spinal hematomas in these patients include:

Use of indwelling epidural catheters
Concomitant use of other drugs that affect hemostasis, such as non-steroidal
anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants.
A history of traumatic or repeated epidural or spinal punctures
A history of spinal deformity or spinal surgery

Monitor patients frequently for signs and symptoms of neurological impairment.
If neurological compromise is noted, urgent treatment is necessary.
Consider the benefits and risks before neuraxial intervention in patients
anticoagulated or to be anticoagulated for thromboprophylaxis [see WARNINGS
AND PRECAUTIONS and DRUG
INTERACTIONS].

DRUG DESCRIPTION



What are the possible side effects of enoxaparin (Lovenox)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers or call your doctor at once if you have any of these serious side effects:

bleeding that won't stop;
pale skin, easy bruising, unusual weakness;
swelling, bruising, or bleeding where an incision was made during a surgery or other medical procedure;
sudden numbness or weakness,...
Read All Potential Side Effects for Lovenox »




Lovenox is a sterile aqueous solution containing enoxaparin sodium, a low molecular weight heparin. The pH of the injection is 5.5 to 7.5.
Enoxaparin sodium is obtained by alkaline depolymerization of heparin benzyl
ester derived from porcine intestinal mucosa. Its structure is characterized
by a 2-O-sulfo-4-enepyranosuronic acid group at the non-reducing end and a 2-N,6-O-disulfo-D-glucosamine
at the reducing end of the chain. About 20% (ranging between 15% and 25%) of
the enoxaparin structure contains an 1,6 anhydro derivative on the reducing
end of the polysaccharide chain. The drug substance is the sodium salt. The
average molecular weight is about 4500 daltons. The molecular weight distribution
is:
<2000 daltons                ≤20%
2000 to 8000 daltons      ≥68%
>8000 daltons                ≤18%

Structural Formula







*X = Percent of polysaccharide chain containing 1,6 anhydro derivative on the reducing end.
Lovenox 100 mg/mL Concentration contains 10 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1000 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
Lovenox 150 mg/mL Concentration contains 15 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1500 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
The Lovenox prefilled syringes and graduated prefilled syringes are preservative-free
and intended for use only as a single-dose injection. The multiple-dose vial
contains 15 mg benzyl alcohol per 1 mL as a preservative [see DOSAGE
AND ADMINISTRATION and HOW SUPPLIED].
Last reviewed on RxList: 1/8/2010




Lovenox Drug Description
Lovenox
(enoxaparin sodium) Injection for Subcutaneous and Intravenous use


WARNING: SPINAL/EPIDURAL HEMATOMAS
Epidural or spinal hematomas may occur in patients who are anticoagulated
with low molecular weight heparins (LMWH) or heparinoids and are receiving
neuraxial anesthesia or undergoing spinal puncture. These hematomas may result
in long-term or permanent paralysis. Consider these risks when scheduling
patients for spinal procedures. Factors that can increase the risk of developing
epidural or spinal hematomas in these patients include:

Use of indwelling epidural catheters
Concomitant use of other drugs that affect hemostasis, such as non-steroidal
anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants.
A history of traumatic or repeated epidural or spinal punctures
A history of spinal deformity or spinal surgery

Monitor patients frequently for signs and symptoms of neurological impairment.
If neurological compromise is noted, urgent treatment is necessary.
Consider the benefits and risks before neuraxial intervention in patients
anticoagulated or to be anticoagulated for thromboprophylaxis [see WARNINGS
AND PRECAUTIONS and DRUG
INTERACTIONS].

DRUG DESCRIPTION



What are the possible side effects of enoxaparin (Lovenox)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers or call your doctor at once if you have any of these serious side effects:

bleeding that won't stop;
pale skin, easy bruising, unusual weakness;
swelling, bruising, or bleeding where an incision was made during a surgery or other medical procedure;
sudden numbness or weakness,...
Read All Potential Side Effects for Lovenox »




Lovenox is a sterile aqueous solution containing enoxaparin sodium, a low molecular weight heparin. The pH of the injection is 5.5 to 7.5.
Enoxaparin sodium is obtained by alkaline depolymerization of heparin benzyl
ester derived from porcine intestinal mucosa. Its structure is characterized
by a 2-O-sulfo-4-enepyranosuronic acid group at the non-reducing end and a 2-N,6-O-disulfo-D-glucosamine
at the reducing end of the chain. About 20% (ranging between 15% and 25%) of
the enoxaparin structure contains an 1,6 anhydro derivative on the reducing
end of the polysaccharide chain. The drug substance is the sodium salt. The
average molecular weight is about 4500 daltons. The molecular weight distribution
is:
<2000 daltons                ≤20%
2000 to 8000 daltons      ≥68%
>8000 daltons                ≤18%

Structural Formula







*X = Percent of polysaccharide chain containing 1,6 anhydro derivative on the reducing end.
Lovenox 100 mg/mL Concentration contains 10 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1000 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
Lovenox 150 mg/mL Concentration contains 15 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1500 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
The Lovenox prefilled syringes and graduated prefilled syringes are preservative-free
and intended for use only as a single-dose injection. The multiple-dose vial
contains 15 mg benzyl alcohol per 1 mL as a preservative [see DOSAGE
AND ADMINISTRATION and HOW SUPPLIED].
Last reviewed on RxList: 1/8/2010




Lovenox Drug Description
Lovenox
(enoxaparin sodium) Injection for Subcutaneous and Intravenous use


WARNING: SPINAL/EPIDURAL HEMATOMAS
Epidural or spinal hematomas may occur in patients who are anticoagulated
with low molecular weight heparins (LMWH) or heparinoids and are receiving
neuraxial anesthesia or undergoing spinal puncture. These hematomas may result
in long-term or permanent paralysis. Consider these risks when scheduling
patients for spinal procedures. Factors that can increase the risk of developing
epidural or spinal hematomas in these patients include:

Use of indwelling epidural catheters
Concomitant use of other drugs that affect hemostasis, such as non-steroidal
anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants.
A history of traumatic or repeated epidural or spinal punctures
A history of spinal deformity or spinal surgery

Monitor patients frequently for signs and symptoms of neurological impairment.
If neurological compromise is noted, urgent treatment is necessary.
Consider the benefits and risks before neuraxial intervention in patients
anticoagulated or to be anticoagulated for thromboprophylaxis [see WARNINGS
AND PRECAUTIONS and DRUG
INTERACTIONS].

DRUG DESCRIPTION



What are the possible side effects of enoxaparin (Lovenox)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers or call your doctor at once if you have any of these serious side effects:

bleeding that won't stop;
pale skin, easy bruising, unusual weakness;
swelling, bruising, or bleeding where an incision was made during a surgery or other medical procedure;
sudden numbness or weakness,...
Read All Potential Side Effects for Lovenox »




Lovenox is a sterile aqueous solution containing enoxaparin sodium, a low molecular weight heparin. The pH of the injection is 5.5 to 7.5.
Enoxaparin sodium is obtained by alkaline depolymerization of heparin benzyl
ester derived from porcine intestinal mucosa. Its structure is characterized
by a 2-O-sulfo-4-enepyranosuronic acid group at the non-reducing end and a 2-N,6-O-disulfo-D-glucosamine
at the reducing end of the chain. About 20% (ranging between 15% and 25%) of
the enoxaparin structure contains an 1,6 anhydro derivative on the reducing
end of the polysaccharide chain. The drug substance is the sodium salt. The
average molecular weight is about 4500 daltons. The molecular weight distribution
is:
<2000 daltons                ≤20%
2000 to 8000 daltons      ≥68%
>8000 daltons                ≤18%

Structural Formula







*X = Percent of polysaccharide chain containing 1,6 anhydro derivative on the reducing end.
Lovenox 100 mg/mL Concentration contains 10 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1000 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
Lovenox 150 mg/mL Concentration contains 15 mg enoxaparin sodium (approximate
anti-Factor Xa activity of 1500 IU [with reference to the W.H.O. First International
Low Molecular Weight Heparin Reference Standard]) per 0.1 mL Water for Injection.
The Lovenox prefilled syringes and graduated prefilled syringes are preservative-free
and intended for use only as a single-dose injection. The multiple-dose vial
contains 15 mg benzyl alcohol per 1 mL as a preservative [see DOSAGE
AND ADMINISTRATION and HOW SUPPLIED].
Last reviewed on RxList: 1/8/2010





Other reviews about Lovenox on wordpress

Sanofi-Aventis 'considering legal options
  by mjabdul
Sanofi-Aventis said it is 'considering all its legal options' after the U.S. Court of Appeals upheld an earlier ruling in the Lovenox anti-coagulant patent infringement suit against Amphastar […]


Lovenox
  by edieweiser
Sanofi-aventis LOVENOX helps protect against DVT blood clots. The CRM program objectives were to 1) define the risk, then 2) establish name recognition,ツand 3) have people ask for the […]


AVONEX
  by edieweiser
Biogen AVONEX is prescribed for multiple sclerosis. The CRM program objectives were to 1) connect with newly diagnosed patients, 2) influence their decision to choose Avonex, and then 3) […]


on to cycle 2
  by dinainsuburbia
Thanks to my admonishing of my menstrual cycle in my last blog, good old Aunt Flo showed up Friday afternoon- EXACTLY the same as the cycle prior.ツ Pretty […]


no love for lovenox!
  by dinainsuburbia
I've posted before about lovenox.ツ I complained about how annoying this drug is- the bruising, the slight burning at the injection site.ツ Heck, just the total pain in […]


Lovenox *gulp*
  by Kate
After my first loss I asked my doctor to run any tests she had to find out why. She was kind of enough to oblige though I've heard […]


Fighting Fear
  by Kate
I've been calm and blase about this pregnancy until yesterday. I think it was the first lovenox injection. Lying down and enduring that painful injection (it hurts more […]


Lovenox and Pregnancy
  by anarchymommy
One of the most searched topics on this blog has been a combo of Lovenox, Pregnancy, and Health Insurance. Frequently searches for "Why doesn't health insurance cover Lovenox […]


Generic Of Sanofi's Anti-Clotting Drug Lovenox Coming from Novartis
  by Doctor Medical News.com
(WSJ) U.S. health regulators Friday approved a generic version of Sanofi-Aventis' (SAN.FR, SNY) blockbuster anti-clotting drug Lovenox, sending shares of the French drugmaker down nearly 5%.ツ The Food […]


Teva copy of Sanofi's Lovenox may be close; Novartis and Momenta Concerned
  by Doctor Medical News.com
(Reuters) - A second generic version of Sanofi-Aventis's (SASY.PA) blood-clot drug Lovenox is likely to reach the U.S. market this year, intensifying competition and pushing down prices, a […]



Other reviews about Lovenox on web:

LOVENOXテδづつョ is an anticoagulant therapy indicated to help reduce the risk of developing DVT, or deep vein thrombosis, which may lead to pulmonary embolism (PE) LOVENOXテδづつョ-: Treatment for Deep Vein Thrombosis (DVT) Blood Clots


Lovenox (enoxaparin) is used to prevent deep vein thrombosis (DVT) which which can lead to blood clots in the lungs. Includes Lovenox side effects, interactions and indications. Lovenox Information from Drugs.com


Learn about the prescription medication Lovenox (Enoxaparin Sodium Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Lovenox (Enoxaparin Sodium Injection) Drug Information: Uses, Side ...


Avoid scams and fraud by dealing locally! Beware any deal involving Western Union, Moneygram, wire transfer, cashier check, money order, shipping, escrow, or any promise ... Re: Lovenox


LOVENOXテδづつョ is an anticoagulant therapy indicated to help reduce the risk of developing DVT, or deep vein thrombosis, which may lead to pulmonary embolism (PE) LOVENOXテδづつョ- About Treatment


Enoxaparin is a low molecular weight heparin marketed as Lovenox or Clexane and as Indenox (India, Marketed by Nucleus). It is used to prevent and treat deep vein thrombosis or ... Enoxaparin sodium - Wikipedia, the free encyclopedia


Accurate, FDA approved Lovenox information for healthcare professionals and patients - brought to you by Drugs.com. Lovenox Official FDA information, side effects and uses.


Consumer information about the medication ENOXAPARIN - INJECTION (Lovenox), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... ENOXAPARIN - INJECTION (Lovenox) side effects, medical uses, and ...


WARNING: SPINAL/EPIDURAL HEMATOMA. Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids ... LOVENOXテδづつョ Professional Online Development


July 29 , 2010 First-time generic approved for Lovenoxテδづつョ On July 23, 2010, the Food and Drug Administration granted marketing approval of the Abbreviated New Drug ... First-time generic approved for Lovenoxテδづつョ





Featured Reviews

Reviews Naftifine

Naftin Gel Drug Description NAFTIN® (naftifine HCL 1%) Gel DRUG DESCRIPTION What are the possible side effects of naftifine topical (Naftin)? Serious side effects of naftifine topical use are not expected. Stop using naftifine...
Read More  |  Review This
Reviews Fiorinal with Codeine

Fiorinal with Codeine Drug Description Fiorinal With Codeine (butalbital, aspirin, caffeine, and codeine phosphate) Capsule DRUG DESCRIPTION What are the possible side effects of aspirin, butalbital, caffeine, and codeine (Fiorinal...
Read More  |  Review This
Reviews Azor

Azor Drug Description Azor® (amlodipine and olmesartan medoxomil) Tablets USE IN PREGNANCY When pregnancy is detected, discontinue Azor as soon as possible. When used in pregnancy during the second and third trimesters, drugs...
Read More  |  Review This
Reviews Demecarium

Humorsol Drug Description DRUG DESCRIPTION What are the possible side effects of demecarium bromide ophthalmic (Humorsol Ocumeter)? Contact your doctor immediately if you notice any decrease in vision or an increase in "floaters"...
Read More  |  Review This
Reviews Soma

Soma Drug Description SOMA (carisoprodol) Tablets for Oral use DRUG DESCRIPTION What are the possible side effects of carisoprodol (Soma, Vanadom)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....